Share of cannabidiol clinical trials worldwide by condition 2010-2023

Published by
Matej Mikulic,
Nov 1, 2023
Between 2010 and 2023, around 30 percent of clinical trials involving cannabidiol (CBD) targeted pain. Epilepsy was the second most targeted medical condition with around 27 percent of trials. This statistic shows the percentage of clinical trials involving CBD worldwide between 2010 and 2023, by targeted medical condition.

Percentage of clinical trials involving cannabidiol (CBD) worldwide between 2010 and 2023, by medical condition

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

August 2023

Region

Worldwide

Survey time period

January 1, 2010 to May 1, 2023

Number of respondents

base: 440 trials

Supplementary notes

This statistic shows a breakdown of trials for which ‘CBD only’ is the intervention.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Medical cannabis in the United Kingdom (UK) "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Medical cannabis in the United Kingdom (UK)

Market overview

8

General use

4

Illegal use for medical reasons

4

Legal medical use

5

Cannabidiol

3

Further Content: You might find this interesting as well

Topics

Medical cannabis in the UKMedical cannabis in the U.S.Medical cannabis in CanadaDrug situation in EuropeRecreational cannabis in Canada
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu